Northern Trust’s Oncorus, Inc. ONCR Stock Holding History

Northern Trust’s Portfolio ONCR Stock Details ONCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-28,525	Closed	-$9.82K	–	4619
2023 Q1	$9.82K	Sell	28,525 -435	-2%	-$162	﹤0.01%	4527
2022 Q4	$7.34K	Hold	28,960	–	–	﹤0.01%	4603
2022 Q3	$24K	Hold	28,960	–	–	﹤0.01%	4519
2022 Q2	$37K	Sell	28,960 -131,772	-82%	-$179K	﹤0.01%	4495
2022 Q1	$286K	Sell	160,732 -11,043	-6%	-$30.9K	﹤0.01%	3973
2021 Q4	$906K	Buy	171,775 +2,995	+2%	+$23.2K	﹤0.01%	3581
2021 Q3	$1.58M	Buy	168,780 +277	+0.2%	+$3.16K	﹤0.01%	3390
2021 Q2	$2.33M	Buy	168,503 +82,843	+97%	+$1.28M	﹤0.01%	3283
2021 Q1	$1.19M	Buy	85,660 +9,881	+13%	+$205K	﹤0.01%	3511
2020 Q4	$2.45M	Buy	+75,779	New	+$1.75M	﹤0.01%	3092

Other funds holding ONCR

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

YAL

Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Northern Trust's ONCR Position: Q2 2023 in Review

Northern Trust sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 28,525 shares — an estimated $9.82K sold.

Northern Trust first reported a position in ONCR in Q4 2020 and held it in 10 quarters. The position peaked at $2.45M in Q4 2020. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

Northern Trust reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
Northern Trust sold 28,525 Oncorus, Inc. shares in Q2 2023, an estimated $9.82K.
Northern Trust first reported a position in Oncorus, Inc. in Q4 2020 and held it in 10 quarters.
Northern Trust's Oncorus, Inc. position peaked at $2.45M in Q4 2020.
4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on Northern Trust's 13F filing for Q2 2023, filed 11 Aug 2023.